Patents by Inventor Yoshinobu Hashimoto

Yoshinobu Hashimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8533429
    Abstract: A memory access control unit is provided with a storage unit for storing a page table that stores a correspondence between a piece of data, a virtual page number, and a physical page number for all pages, and a conversion unit that includes a buffer for storing, for each of a subset of the pages, the virtual page number and the physical page number in correspondence, and a conversion processing unit operable to convert a virtual address into a physical address in accordance with content stored in the buffer.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: September 10, 2013
    Assignee: Panasonic Corporation
    Inventors: Masaki Maeda, Yorihiko Wakayama, Koji Asai, Masahiro Ishii, Hiroshi Amano, Yoshinobu Hashimoto
  • Patent number: 8354898
    Abstract: A harmonic suppression resonator comprises a plurality of waveguide resonators that resonate in TE mode, in which harmonic suppression resonator, adjoining resonators are coupled via a plurality of coupling windows. Four coupling windows 33bc1, 33bc2, 33bc3 and 33bc4 are provided between a resonant region 51b and a resonant region adjoining the resonant region 51b. These coupling windows allow fundamental wave modes of the adjoining resonators to be coupled mainly by magnetically coupling. The coupling windows 33bc3 and 33bc4 allow second harmonic modes of the adjoining resonators to be electrically coupled, and the coupling windows 33bc1 and 33bc2 allow the second harmonic modes of the adjoining resonators to be magnetically coupled. By causing the amount of the electrically coupling and the amount of the magnetically coupling to be substantially equal, the coupling of the second harmonic modes is negated, whereby propagation of the second harmonic is blocked.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: January 15, 2013
    Assignee: Furuno Electric Company Limited
    Inventors: Ken'ichi Iio, Mitsuru Makihara, Hiroshi Nagata, Yoshinobu Hashimoto
  • Publication number: 20110161622
    Abstract: A memory access control unit is provided with a storage unit for storing a page table that stores a correspondence between a piece of data, a virtual page number, and a physical page number for all pages, and a conversion unit that includes a buffer for storing, for each of a subset of the pages, the virtual page number and the physical page number in correspondence, and a conversion processing unit operable to convert a virtual address into a physical address in accordance with content stored in the buffer.
    Type: Application
    Filed: April 26, 2010
    Publication date: June 30, 2011
    Inventors: Masaki Maeda, Yorihiko Wakayama, Koji Asai, Masahiro Ishii, Hiroshi Amano, Yoshinobu Hashimoto
  • Publication number: 20090201106
    Abstract: A harmonic suppression resonator comprises a plurality of waveguide resonators that resonate in TE mode, in which harmonic suppression resonator, adjoining resonators are coupled via a plurality of coupling windows. Four coupling windows 33bc1, 33bc2, 33bc3 and 33bc4 are provided between a resonant region 51b and a resonant region adjoining the resonant region 51b. These coupling windows allow fundamental wave modes of the adjoining resonators to be coupled mainly by magnetically coupling. The coupling windows 33bc3 and 33bc4 allow second harmonic modes of the adjoining resonators to be electrically coupled, and the coupling windows 33bc1 and 33bc2 allow the second harmonic modes of the adjoining resonators to be magnetically coupled. By causing the amount of the electrically coupling and the amount of the magnetically coupling to be substantially equal, the coupling of the second harmonic modes is negated, whereby propagation of the second harmonic is blocked.
    Type: Application
    Filed: December 23, 2008
    Publication date: August 13, 2009
    Inventors: Ken'ichi Iio, Mitsuru Makihara, Hiroshi Nagata, Yoshinobu Hashimoto
  • Publication number: 20080270744
    Abstract: The present invention allows a buffer memory to be shared for data streams, while maintaining space efficiency of the buffer memory. A buffer memory sharing apparatus allowing the buffer memory to be shared includes: a flag managing circuit which manages flags each indicating an occupancy status of a region; and, for the each data stream, an address generating circuit. The address generating circuit includes: an occupancy managing circuit which manages exclusive allocation of regions based on the flags; a FIFO memory which stores a bit sequence indicating an allocated region; a write counter; and a read counter. The address generating circuit generates a write address by combining a bit sequence stored at an end of the FIFO memory and a value of the write counter, and generates a read address by combining a bit sequence stored at a start of the FIFO memory and a value of the read counter.
    Type: Application
    Filed: April 24, 2008
    Publication date: October 30, 2008
    Inventor: Yoshinobu Hashimoto
  • Patent number: 7387781
    Abstract: A composition that effectively prevents the manifestation of osteoporosis, the formation of osteoclasts and suppresses a decrease of spongy bone density. The composition primarily contains Cordyceps sinensis or its processed product.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: June 17, 2008
    Assignee: Simpson Biotech Co., Ltd.
    Inventors: Shigetoshi Kadota, Yoshinobu Hashimoto, Chia-Chin Sheu
  • Patent number: 7311919
    Abstract: Compositions and methods for treating osteoporosis, the formation of osteoeclasts, and/or for the suppression of decreasing spongy bone density. Example methods include administering Cordyceps sinensis or its processed product.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: December 25, 2007
    Assignee: Simpson Biotech Co., Ltd.
    Inventors: Shigetoshi Kadota, Yoshinobu Hashimoto, Chia-Chin Sheu
  • Publication number: 20070014811
    Abstract: The present invention provides a composition that effectively prevents the manifestation of osteoporosis, the formation of osteoclasts and the suppression of decreasing spongy bone density. The composition primarily contains Cordyceps Sinensis or its processed product.
    Type: Application
    Filed: September 20, 2006
    Publication date: January 18, 2007
    Inventors: Shigetoshi Kadota, Yoshinobu Hashimoto, Chia-Chin Sheu
  • Publication number: 20050013830
    Abstract: The present invention provides a composition that effectively presents the manifestation of osteoporosis, the formation of osteoclasts and the suppression of decreasing spongy bone density. The composition primarily contains Cordyceps Sinensis or its processed product.
    Type: Application
    Filed: April 16, 2004
    Publication date: January 20, 2005
    Inventors: Shigetoshi Kadota, Yoshinobu Hashimoto, Chia-Chin Sheu
  • Patent number: 4873208
    Abstract: Disclosed is a holder for sealing member, in which at least a portion of the holder which comes into contact with the member comprises a sintered body comprising as a main component a non-oxide ceramic of silicon nitride, aluminum nitride, sialon or silicon carbide.By the use of the holder according to this invention, in the hermetic sealing process which is carried out continuously and automatically, an exchange frequency of the holder can be decreased remarkably, and thus a working efficiency on a manufacturing line can be increased. In consequence, the holder according to this invention is industrially very useful, and in particular, it is suitable for the hermetic sealing of the panel pins for cathode ray tubes.
    Type: Grant
    Filed: October 19, 1987
    Date of Patent: October 10, 1989
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Mitsuhiro Nagata, Tadashi Hayashi, Yoshinobu Hashimoto, Kiyoshi Nakamura
  • Patent number: 4613505
    Abstract: There is provided a fat emulsion of an ester of flurbiprofen having the formula ##STR1## wherein R is a group of the formula ##STR2## wherein R.sub.1 is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, R.sub.2 is a C.sub.1 -C.sub.15 alkyl group or a C.sub.2 -C.sub.8 alkenyl group, and m is zero or an integer of 1; or a lactone group of the formula ##STR3## wherein R.sub.3 and R.sub.4 are same as or different from each other and are a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, and n is an integer of 1 or 2.The emulsion containing particles of a vegetable oil dissolving the ester can be orally or parenterally administered to human or animal for analgesia, antiphlogosis and antipyresis in various diseases and exhibits a high activity with small amounts in terms of flurbiprofen as compared with flurbiprofen itself.
    Type: Grant
    Filed: June 19, 1984
    Date of Patent: September 23, 1986
    Assignees: The Green Cross Corporation, Kaken Pharmaceutical Co., Ltd.
    Inventors: Yutaka Mizushima, Katsuhiro Uchida, Shozoh Masumoto, Masao Tohno, Yoshinobu Hashimoto, Kazumasa Yokoyama, Hiroyuki Okamoto, Kiichiro Nabeta, Tadakazu Suyama
  • Patent number: 4364941
    Abstract: A method for regulating the bone metabolism of a warm-blooded animal, which comprises administering pharmaceutically effective amounts of 1.alpha., 24-dihydroxycholecalciferol (1.alpha., 24-DHCC) and 24,25-dihydroxycholecalciferol (24,25-DHCC) to said warm-blooded animal, and a pharmaceutical composition comprising 1.alpha.,24-DHCC, 24,25-DHCC and a pharmaceutically acceptable carrier.According to the invention, a condition of abnormal bone metabolism requiring long-term therapy, such as osteoporosis, can be safely treated by administering 1.alpha., 24-DHCC and 24,25-DHCC over a long period of time because no substantial adverse effect of 1.alpha., 24-DHCC on the metabolis of 24,25-DHCC is observed.
    Type: Grant
    Filed: August 31, 1981
    Date of Patent: December 21, 1982
    Assignees: Teijin Limited, Teijin Pharmaceutical Co., Ltd.
    Inventors: Mamoru Kiyoki, Hiroyoshi Endo, Tatsuyuki Naruchi, Yoshinobu Hashimoto
  • Patent number: 4305935
    Abstract: This is a bone formation stimulant containing vitamin D.sub.3 or its derivative and acetylsalicylic acid or its formaceutically permissible salt. The present bone formation stimulant is used to cure or prevent the diseases caused by the deficiency of vitamin D or related diseases by dosing human beings or animals with it.
    Type: Grant
    Filed: April 9, 1980
    Date of Patent: December 15, 1981
    Assignee: Teijin Limited
    Inventors: Hiroyuki Kawashima, Minoru Hayashi, Seiji Kurozumi, Yoshiki Suzuki, Yoshinobu Hashimoto
  • Patent number: 4180672
    Abstract: Organothiocyclopentanes of the formula ##STR1## wherein E represents >C.dbd.O or ##STR2## in which Z' represents a hydrogen atom, a hydroxyl group or a protected hydroxyl group; X represents --S--, --CH.sub.2 --, --CH.dbd.; represents a single or double bond; R' represents a monovalent or divalent organic group containing 1 to 25 carbon atoms; R represents a monovalent organic group containing 1 to 25 carbon atoms; Z represents a hydrogen atom, a hydroxyl group or a protected hydroxyl group; and when both E and Z represent a hydroxyl group or a protected hydroxyl group, X represents --S--.Also, 2-organothio-2-cyclopentenones of the formula ##STR3## wherein R and Z are as defined above. The compounds of formula (I) are prepared by reacting 2,3-epoxy-cyclopentanone or its derivatives with mercaptans in the presence of basic compounds.
    Type: Grant
    Filed: March 7, 1977
    Date of Patent: December 25, 1979
    Assignee: Teijin Limited
    Inventors: Seizi Kurozumi, Takeshi Toru, Makiko Kobayashi, Yoshinobu Hashimoto
  • Patent number: 4169150
    Abstract: Novel 4H-pyrrolo[1,2-a][1,4]benzodiazepine derivatives of the formula ##STR1## wherein at least one of R.sub.1, R.sub.2 and R.sub.3 represent lower alkyl and the remainder hydrogen, R.sub.4 represents hydrogen or lower alkyl, ring A optionally contains at least one substituent selected from halogen, nitro and trifluoromethyl, and ring B optionally contains at least one substituent selected from halogen, nitro, trifluoromethyl, lower alkyl and lower alkoxy; and novel intermediates thereof expressed by the formula ##STR2## wherein Z represents protected amino. Compounds of formula (I) are prepared by subjecting compounds of formula (II) to protective group-elimination and cyclization. The compounds of formula (I) and acid addition salts thereof have useful anti-anxietic, sedative, anti-convulsant, muscle relaxant and hypnotic, and their toxicity is low.
    Type: Grant
    Filed: November 2, 1976
    Date of Patent: September 25, 1979
    Assignee: Teijin Limited
    Inventors: Takeshi Hara, Yasutaka Kayama, Kazuhiko Itoh, Toshiro Mori, Hitoshi Fujimori, Tamiko Sunami, Yoshinobu Hashimoto, Sachio Ishimoto
  • Patent number: 4022891
    Abstract: Novel 1.alpha., 24-dihydroxycholecalciferol and derivatives thereof which are useful with reduced side-effects for the treatment of abnormal metabolism of calcium and phosphorus caused by liver failure, renal failure, gastrointestinal tract failure and parathyroid failure, and related bone diseases. Preparation of the novel 1.alpha., 24-dihydroxycholecalciferol and their derivatives starts from 1.alpha., 24-dihydroxycholesterol prepared by reacting 1.alpha., 2.alpha.-epoxy-24-keto-cholesta-4,6-dien-3-one with an alkali metal and a proton donor in the presence of liquid ammonia or a liquid amine. Reaction of the 1.alpha., 24-dihydroxycholesterol with an allylic brominating agent, followed by contacting with a dehydrobrominating agent, affords 1.alpha.,3.beta., 24-trihydroxycholesta-5,7-diene derivative, which can then be converted to 1.alpha., 24-dihydroxycholocalciferol by ultraviolet irradiation in a organic solvent, followed by isomerization. Processes are also provided for separating 1.alpha.
    Type: Grant
    Filed: June 2, 1975
    Date of Patent: May 10, 1977
    Assignee: Teijin Limited
    Inventors: Toru Takeshita, Yoshinobu Hashimoto, Hiroyuki Kawashima, Sachio Ishimoto, Nobuo Ikekawa, Masuo Morisaki
  • Patent number: 3958008
    Abstract: The thioallophanate compound represented by the following general formula ##EQU1## wherein X is hydrogen, chlorine atom, nitro or methyl group: Z is a substituting group selected from the group consisting of ##EQU2## and ##EQU3## has excellent anthelmintic activity and can be used for controlling helminthiasis of animals.
    Type: Grant
    Filed: December 28, 1970
    Date of Patent: May 18, 1976
    Assignee: Nippon Soda Company Limited
    Inventors: Yoshinobu Hashimoto, Kinpei Kato, Nobuo Sato